Phenominer Database Results (50 results)

 

How to display a graph
Strain Phenotype Conditions Study Experiment Name Sex Age # of Animals Value Units SEM SD Method Method Duration Post Insult Type Post Insult Time Value Post Insult Time Unit Clinical Measurement Notes Record ID Study ID
SS.ZUC-Leprfa-/-/Slc inguinal fat pad weight to tibia length ratio control condition Uchinaka A, et al., Pharmacol Res Perspect. 2017 Aug;5(4). doi: 10.1002/prp2.331. inguinal fat pad mass male 91 days 7 1105.49 mg/mm 59.28 156.84 post excision weight measurement 0.0 0 if/tl 101781 2641
SS.ZUC-Leprfa-/-/Slc heart weight to tibia length ratio atorvastatin (6 mg/kg/d) (for 28 days) Yamada Y, et al., Int J Cardiol. 2017 Aug 1;240:332-338. doi: 10.1016/j.ijcard.2017.04.103. Epub 2017 May 4. heart mass male 91 days 13 0.42 g/cm 0.01 0.04 post excision weight measurement 0.0 0 101975 2644
SS.ZUC-Leprfa-/-/Slc epididymal fat pad weight to tibia length ratio atorvastatin (6 mg/kg/d) (for 28 days) Yamada Y, et al., Int J Cardiol. 2017 Aug 1;240:332-338. doi: 10.1016/j.ijcard.2017.04.103. Epub 2017 May 4. epididymal fat pad mass male 91 days 13 3.58 g/cm 0.12 0.42 post excision weight measurement 0.0 0 ef/tl 101984 2644
SS.ZUC-Leprfa-/-/Slc mesenteric fat pad weight to tibia length ratio atorvastatin (20 mg/kg/d) (for 28 days) Yamada Y, et al., Int J Cardiol. 2017 Aug 1;240:332-338. doi: 10.1016/j.ijcard.2017.04.103. Epub 2017 May 4. mesenteric fat pad mass male 91 days 13 348.17 mg/mm 9.57 34.51 post excision weight measurement 0.0 0 mf/tl, mesenteric fat pad weight to tibia length ratio 101988 2644
SS.ZUC-Leprfa-/-/Slc heart weight to tibia length ratio bilateral ovariectomy (for 42 days) then vehicle control condition (for 35 days) Murase T, et al., Hypertension. 2012 Mar;59(3):694-704. doi: 10.1161/HYPERTENSIONAHA.111.180976. Epub 2012 Jan 23. heart mass female 91 days 8 0.35 g/cm 0.0 0.0 post excision weight measurement 0.0 ovariectomy 42 days 101693 2622
SS.ZUC-Leprfa-/-/Slc heart weight to tibia length ratio control condition Uchinaka A, et al., Pharmacol Res Perspect. 2017 Aug;5(4). doi: 10.1002/prp2.331. heart mass male 91 days 7 0.43 g/cm 0.01 0.0 post excision weight measurement 0.0 0 101757 2641
SS.ZUC-Leprfa-/-/Slc heart left ventricle weight to tibia length ratio control condition Uchinaka A, et al., Pharmacol Res Perspect. 2017 Aug;5(4). doi: 10.1002/prp2.331. heart left ventricle mass male 91 days 7 0.32 g/cm 0.01 0.01 post excision weight measurement 0.0 0 lv/tl 101761 2641
SS.ZUC-Leprfa-/-/Slc heart weight to tibia length ratio control condition Hattori T, et al., Nutr Diabetes. 2011 Jan 31;1:e1. doi: 10.1038/nutd.2010.1. heart mass male 126 days 7 0.42 g/cm 0.0 0.01 post excision weight measurement 0.0 0 101894 2642
SS.ZUC-Leprfa-/-/Slc heart left atrium weight to tibia length ratio control condition Hattori T, et al., Nutr Diabetes. 2011 Jan 31;1:e1. doi: 10.1038/nutd.2010.1. heart left atrium mass male 126 days 7 2.55 mg/mm 0.14 0.37 post excision weight measurement 0.0 0 a/tl 101900 2642
SS.ZUC-Leprfa-/-/Slc retroperitoneal fat pad weight to tibia length ratio control condition Hattori T, et al., Nutr Diabetes. 2011 Jan 31;1:e1. doi: 10.1038/nutd.2010.1. retroperitoneal fat pad mass male 126 days 7 839.28 mg/mm 33.0 87.31 post excision weight measurement 0.0 0 rf/tl 101906 2642
SS.ZUC-Leprfa-/-/Slc inguinal fat pad weight to tibia length ratio everolimus (0.83 mg/kg/d) (for 28 days) Uchinaka A, et al., Pharmacol Res Perspect. 2017 Aug;5(4). doi: 10.1002/prp2.331. inguinal fat pad mass male 91 days 12 765.81 mg/mm 23.86 82.65 post excision weight measurement 0.0 0 if/tl 101782 2641
SS.ZUC-Leprfa-/-/Slc retroperitoneal fat pad weight to tibia length ratio bilateral ovariectomy (for 42 days) then 17 beta-estradiol (0.5 mg) (for 35 days) Murase T, et al., Hypertension. 2012 Mar;59(3):694-704. doi: 10.1161/HYPERTENSIONAHA.111.180976. Epub 2012 Jan 23. retroperitoneal fat pad mass female 91 days 7 377.0 mg/mm 33.0 87.31 post excision weight measurement 0.0 ovariectomy 42 days 101702 2622
SS.ZUC-Leprfa-/-/Slc single kidney weight to tibia length ratio control condition Uchinaka A, et al., Pharmacol Res Perspect. 2017 Aug;5(4). doi: 10.1002/prp2.331. kidney mass male 91 days 7 33.51 g/cm 0.99 2.62 post excision weight measurement 0.0 0 101769 2641
SS.ZUC-Leprfa-/-/Slc heart weight to tibia length ratio atorvastatin (20 mg/kg/d) (for 28 days) Yamada Y, et al., Int J Cardiol. 2017 Aug 1;240:332-338. doi: 10.1016/j.ijcard.2017.04.103. Epub 2017 May 4. heart mass male 91 days 13 0.43 g/cm 0.01 0.04 post excision weight measurement 0.0 0 101976 2644
SS.ZUC-Leprfa-/-/Slc heart left ventricle weight to tibia length ratio atorvastatin (6 mg/kg/d) (for 28 days) Yamada Y, et al., Int J Cardiol. 2017 Aug 1;240:332-338. doi: 10.1016/j.ijcard.2017.04.103. Epub 2017 May 4. heart left ventricle mass male 91 days 13 0.3 g/cm 0.01 0.03 post excision weight measurement 0.0 0 lv/tl 101978 2644
SS.ZUC-Leprfa-/-/Slc retroperitoneal fat pad weight to tibia length ratio vehicle control condition (0.5 %) (for 28 days) Yamada Y, et al., Int J Cardiol. 2017 Aug 1;240:332-338. doi: 10.1016/j.ijcard.2017.04.103. Epub 2017 May 4. retroperitoneal fat pad mass male 91 days 13 429.56 mg/mm 13.64 49.18 post excision weight measurement 0.0 0 rf/tl 101980 2644
SS.ZUC-Leprfa-/-/Slc epididymal fat pad weight to tibia length ratio vehicle control condition (0.5 %) (for 28 days) Yamada Y, et al., Int J Cardiol. 2017 Aug 1;240:332-338. doi: 10.1016/j.ijcard.2017.04.103. Epub 2017 May 4. epididymal fat pad mass male 91 days 13 3.55 g/cm 0.1 0.35 post excision weight measurement 0.0 0 ef/tl 101983 2644
SS.ZUC-Leprfa-/-/Slc epididymal fat pad weight to tibia length ratio atorvastatin (20 mg/kg/d) (for 28 days) Yamada Y, et al., Int J Cardiol. 2017 Aug 1;240:332-338. doi: 10.1016/j.ijcard.2017.04.103. Epub 2017 May 4. epididymal fat pad mass male 91 days 13 3.62 g/cm 0.09 0.34 post excision weight measurement 0.0 0 ef/tl 101985 2644
SS.ZUC-Leprfa-/-/Slc mesenteric fat pad weight to tibia length ratio vehicle control condition (0.5 %) (for 28 days) Yamada Y, et al., Int J Cardiol. 2017 Aug 1;240:332-338. doi: 10.1016/j.ijcard.2017.04.103. Epub 2017 May 4. mesenteric fat pad mass male 91 days 13 364.22 mg/mm 10.33 37.25 post excision weight measurement 0.0 0 mf/tl 101986 2644
SS.ZUC-Leprfa-/-/Slc liver weight to tibia length ratio control condition Uchinaka A, et al., Pharmacol Res Perspect. 2017 Aug;5(4). doi: 10.1002/prp2.331. liver mass male 91 days 7 612.89 mg/mm 31.39 83.05 post excision weight measurement 0.0 0 liv/tl 101765 2641
SS.ZUC-Leprfa-/-/Slc liver weight to tibia length ratio everolimus (0.83 mg/kg/d) (for 28 days) Uchinaka A, et al., Pharmacol Res Perspect. 2017 Aug;5(4). doi: 10.1002/prp2.331. liver mass male 91 days 12 568.94 mg/mm 19.5 67.55 post excision weight measurement 0.0 0 liv/tl 101766 2641
SS.ZUC-Leprfa-/-/Slc liver weight to tibia length ratio control condition Hattori T, et al., Nutr Diabetes. 2011 Jan 31;1:e1. doi: 10.1038/nutd.2010.1. liver mass male 126 days 7 600.11 mg/mm 42.14 111.49 post excision weight measurement 0.0 0 liv/tl 101904 2642
SS.ZUC-Leprfa-/-/Slc mesenteric fat pad weight to tibia length ratio atorvastatin (6 mg/kg/d) (for 28 days) Yamada Y, et al., Int J Cardiol. 2017 Aug 1;240:332-338. doi: 10.1016/j.ijcard.2017.04.103. Epub 2017 May 4. mesenteric fat pad mass male 91 days 13 371.46 mg/mm 9.6 34.61 post excision weight measurement 0.0 0 mf/tl 101987 2644
SS.ZUC-Leprfa-/-/Slc heart left ventricle weight to tibia length ratio bilateral ovariectomy (for 42 days) then vehicle control condition (for 35 days) Murase T, et al., Hypertension. 2012 Mar;59(3):694-704. doi: 10.1161/HYPERTENSIONAHA.111.180976. Epub 2012 Jan 23. heart left ventricle mass female 91 days 8 0.28 g/cm 0.01 0.02 post excision weight measurement 0.0 ovariectomy 42 days lv/tl 101697 2622
SS.ZUC-Leprfa-/-/Slc inguinal fat pad weight to tibia length ratio bilateral ovariectomy (for 42 days) then vehicle control condition (for 35 days) Murase T, et al., Hypertension. 2012 Mar;59(3):694-704. doi: 10.1161/HYPERTENSIONAHA.111.180976. Epub 2012 Jan 23. inguinal fat pad mass female 91 days 8 209.0 mg/mm 12.0 33.94 post excision weight measurement 0.0 ovariectomy 42 days sf/tl 101705 2622
SS.ZUC-Leprfa-/-/Slc heart left ventricle weight to tibia length ratio everolimus (0.83 mg/kg/d) (for 28 days) Uchinaka A, et al., Pharmacol Res Perspect. 2017 Aug;5(4). doi: 10.1002/prp2.331. heart left ventricle mass male 91 days 12 0.25 g/cm 0.0 0.01 post excision weight measurement 0.0 0 lv/tl 101762 2641
SS.ZUC-Leprfa-/-/Slc retroperitoneal fat pad weight to tibia length ratio control condition Uchinaka A, et al., Pharmacol Res Perspect. 2017 Aug;5(4). doi: 10.1002/prp2.331. retroperitoneal fat pad mass male 91 days 7 399.11 mg/mm 19.55 51.72 post excision weight measurement 0.0 0 rf/tl 101773 2641
SS.ZUC-Leprfa-/-/Slc epididymal fat pad weight to tibia length ratio everolimus (0.83 mg/kg/d) (for 28 days) Uchinaka A, et al., Pharmacol Res Perspect. 2017 Aug;5(4). doi: 10.1002/prp2.331. epididymal fat pad mass male 91 days 12 2.43 g/cm 0.1 0.35 post excision weight measurement 0.0 0 ef/tl 101778 2641
SS.ZUC-Leprfa-/-/Slc heart left ventricle weight to tibia length ratio bilateral ovariectomy (for 42 days) then 17 beta-estradiol (0.5 mg) (for 35 days) Murase T, et al., Hypertension. 2012 Mar;59(3):694-704. doi: 10.1161/HYPERTENSIONAHA.111.180976. Epub 2012 Jan 23. heart left ventricle mass female 91 days 7 0.28 g/cm 0.01 0.02 post excision weight measurement 0.0 ovariectomy 42 days 101698 2622
SS.ZUC-Leprfa-/-/Slc retroperitoneal fat pad weight to tibia length ratio bilateral ovariectomy (for 42 days) then vehicle control condition (for 35 days) Murase T, et al., Hypertension. 2012 Mar;59(3):694-704. doi: 10.1161/HYPERTENSIONAHA.111.180976. Epub 2012 Jan 23. retroperitoneal fat pad mass female 91 days 8 482.0 mg/mm 18.0 50.91 post excision weight measurement 0.0 ovariectomy 42 days vf/tl 101701 2622
SS.ZUC-Leprfa-/-/Slc inguinal fat pad weight to tibia length ratio bilateral ovariectomy (for 42 days) then 17 beta-estradiol (0.5 mg) (for 35 days) Murase T, et al., Hypertension. 2012 Mar;59(3):694-704. doi: 10.1161/HYPERTENSIONAHA.111.180976. Epub 2012 Jan 23. inguinal fat pad mass female 91 days 7 155.0 mg/mm 14.0 37.04 post excision weight measurement 0.0 ovariectomy 42 days sf/tl 101706 2622
SS.ZUC-Leprfa-/-/Slc inguinal fat pad weight to tibia length ratio atorvastatin (20 mg/kg/d) (for 28 days) Yamada Y, et al., Int J Cardiol. 2017 Aug 1;240:332-338. doi: 10.1016/j.ijcard.2017.04.103. Epub 2017 May 4. inguinal fat pad mass male 91 days 13 1482.16 mg/mm 53.88 194.27 post excision weight measurement 0.0 0 if/tl 101991 2644
SS.ZUC-Leprfa-/-/Slc heart weight to tibia length ratio bilateral ovariectomy (for 42 days) then 17 beta-estradiol (0.5 mg) (for 35 days) Murase T, et al., Hypertension. 2012 Mar;59(3):694-704. doi: 10.1161/HYPERTENSIONAHA.111.180976. Epub 2012 Jan 23. heart mass female 91 days 7 0.35 g/cm 0.0 0.0 post excision weight measurement 0.0 ovariectomy 42 days 101694 2622
SS.ZUC-Leprfa-/-/Slc pancreas weight to tibia length everolimus (0.83 mg/kg/d) (for 28 days) Uchinaka A, et al., Pharmacol Res Perspect. 2017 Aug;5(4). doi: 10.1002/prp2.331. pancreas mass male 91 days 12 29.85 mg/mm 1.97 6.82 post excision weight measurement 0.0 0 p/tl 101836 2641
SS.ZUC-Leprfa-/-/Slc heart left ventricle weight to tibia length ratio control condition Hattori T, et al., Nutr Diabetes. 2011 Jan 31;1:e1. doi: 10.1038/nutd.2010.1. heart left ventricle mass male 126 days 7 0.33 g/cm 0.0 0.01 post excision weight measurement 0.0 0 lv/tl 101896 2642
SS.ZUC-Leprfa-/-/Slc heart left ventricle weight to right ventricle weight ratio control condition Hattori T, et al., Nutr Diabetes. 2011 Jan 31;1:e1. doi: 10.1038/nutd.2010.1. heart left ventricle mass male 126 days 7 4.74 null 0.12 0.32 post excision weight measurement 0.0 0 lv/rv 101898 2642
SS.ZUC-Leprfa-/-/Slc retroperitoneal fat pad weight to tibia length ratio everolimus (0.83 mg/kg/d) (for 28 days) Uchinaka A, et al., Pharmacol Res Perspect. 2017 Aug;5(4). doi: 10.1002/prp2.331. retroperitoneal fat pad mass male 91 days 12 334.74 mg/mm 9.21 31.9 post excision weight measurement 0.0 0 rf/tl 101774 2641
SS.ZUC-Leprfa-/-/Slc inguinal fat pad weight to tibia length ratio atorvastatin (6 mg/kg/d) (for 28 days) Yamada Y, et al., Int J Cardiol. 2017 Aug 1;240:332-338. doi: 10.1016/j.ijcard.2017.04.103. Epub 2017 May 4. inguinal fat pad mass male 91 days 13 1448.07 mg/mm 60.58 218.42 post excision weight measurement 0.0 0 if/tl 101990 2644
SS.ZUC-Leprfa-/-/Slc pancreas weight to tibia length control condition Uchinaka A, et al., Pharmacol Res Perspect. 2017 Aug;5(4). doi: 10.1002/prp2.331. pancreas mass male 91 days 7 28.68 mg/mm 1.66 4.39 post excision weight measurement 0.0 0 p/tl 101835 2641
SS.ZUC-Leprfa-/-/Slc single kidney weight to tibia length ratio everolimus (0.83 mg/kg/d) (for 28 days) Uchinaka A, et al., Pharmacol Res Perspect. 2017 Aug;5(4). doi: 10.1002/prp2.331. kidney mass male 91 days 12 25.22 g/cm 0.65 2.26 post excision weight measurement 0.0 0 101770 2641
SS.ZUC-Leprfa-/-/Slc heart left ventricle weight to tibia length ratio vehicle control condition (0.5 %) (for 28 days) Yamada Y, et al., Int J Cardiol. 2017 Aug 1;240:332-338. doi: 10.1016/j.ijcard.2017.04.103. Epub 2017 May 4. heart left ventricle mass male 91 days 13 0.31 g/cm 0.01 0.03 post excision weight measurement 0.0 0 lv/tl 101977 2644
SS.ZUC-Leprfa-/-/Slc retroperitoneal fat pad weight to tibia length ratio atorvastatin (6 mg/kg/d) (for 28 days) Yamada Y, et al., Int J Cardiol. 2017 Aug 1;240:332-338. doi: 10.1016/j.ijcard.2017.04.103. Epub 2017 May 4. retroperitoneal fat pad mass male 91 days 13 415.13 mg/mm 12.15 43.81 post excision weight measurement 0.0 0 rf/tl 101981 2644
SS.ZUC-Leprfa-/-/Slc retroperitoneal fat pad weight to tibia length ratio atorvastatin (20 mg/kg/d) (for 28 days) Yamada Y, et al., Int J Cardiol. 2017 Aug 1;240:332-338. doi: 10.1016/j.ijcard.2017.04.103. Epub 2017 May 4. retroperitoneal fat pad mass male 91 days 13 429.58 mg/mm 14.03 50.59 post excision weight measurement 0.0 0 rf/tl 101982 2644
SS.ZUC-Leprfa-/-/Slc inguinal fat pad weight to tibia length ratio vehicle control condition (0.5 %) (for 28 days) Yamada Y, et al., Int J Cardiol. 2017 Aug 1;240:332-338. doi: 10.1016/j.ijcard.2017.04.103. Epub 2017 May 4. inguinal fat pad mass male 91 days 13 1501.32 mg/mm 68.53 247.09 post excision weight measurement 0.0 0 if/tl 101989 2644
SS.ZUC-Leprfa-/-/Slc heart weight to tibia length ratio vehicle control condition (0.5 %) (for 28 days) Yamada Y, et al., Int J Cardiol. 2017 Aug 1;240:332-338. doi: 10.1016/j.ijcard.2017.04.103. Epub 2017 May 4. heart mass male 91 days 13 0.43 g/cm 0.01 0.04 post excision weight measurement 0.0 0 101974 2644
SS.ZUC-Leprfa-/-/Slc heart left ventricle weight to tibia length ratio atorvastatin (20 mg/kg/d) (for 28 days) Yamada Y, et al., Int J Cardiol. 2017 Aug 1;240:332-338. doi: 10.1016/j.ijcard.2017.04.103. Epub 2017 May 4. heart left ventricle mass male 91 days 13 0.31 g/cm 0.01 0.03 post excision weight measurement 0.0 0 lv/tl 101979 2644
SS.ZUC-Leprfa-/-/Slc heart weight to tibia length ratio everolimus (0.83 mg/kg/d) (for 28 days) Uchinaka A, et al., Pharmacol Res Perspect. 2017 Aug;5(4). doi: 10.1002/prp2.331. heart mass male 91 days 12 0.34 g/cm 0.0 0.0 post excision weight measurement 0.0 0 101758 2641
SS.ZUC-Leprfa-/-/Slc both kidneys wet weight to tibia length ratio control condition Hattori T, et al., Nutr Diabetes. 2011 Jan 31;1:e1. doi: 10.1038/nutd.2010.1. kidney mass male 126 days 7 1.29 g/cm 0.04 0.1 post excision weight measurement 0.0 0 101902 2642
SS.ZUC-Leprfa-/-/Slc inguinal fat pad weight to tibia length ratio control condition Hattori T, et al., Nutr Diabetes. 2011 Jan 31;1:e1. doi: 10.1038/nutd.2010.1. inguinal fat pad mass male 126 days 7 795.02 mg/mm 41.33 109.35 post excision weight measurement 0.0 0 if/tl 101908 2642
SS.ZUC-Leprfa-/-/Slc epididymal fat pad weight to tibia length ratio control condition Uchinaka A, et al., Pharmacol Res Perspect. 2017 Aug;5(4). doi: 10.1002/prp2.331. epididymal fat pad mass male 91 days 7 3.17 g/cm 0.12 0.32 post excision weight measurement 0.0 0 ef/tl 101777 2641